61st European Association for the Study of Diabetes (EASD) Annual Meeting – Oral Presentation #66 Sep 16, 2025 Supporting Materials Icovamenib and Semaglutide Combination Therapy Enhances Body Weight Loss and Glycemic Control While Preserving Lean Mass in a Type 2 Diabetes Animal Model 1.7 MB
Icovamenib and Semaglutide Combination Therapy Enhances Body Weight Loss and Glycemic Control While Preserving Lean Mass in a Type 2 Diabetes Animal Model 1.7 MB
